29241-62-1
29241-62-1
Chemical Structure
5-Bromo-6-chloronicotinic acid
- CAS No.: 29241-62-1
- Formula:C6H3BrClNO2
- Molecular Weight:236.45
IUPAC Name: 5-bromo-6-chloronicotinic acid
InChIKey: DXEUARPQHJXMII-UHFFFAOYSA-N
SMILES: BrC(C=C(C(O)=O)C=N1)=C1Cl
Biological Activity: 5-Bromo-6-chloronicotinic acid is a halogenated nicotinic acid and synthetic starting material that can be used in studies related to organic synthesis[1][2][3].
| Cat. No. | Product Name | Purity | Description | Pricing | |||||||||||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
|
|
5-Bromo-6-chloronicotinic acid | 97.34% | 5-Bromo-6-chloronicotinic acid is a halogenated nicotinic acid and synthetic starting material that can be used in studies related to organic synthesis. | ||||||||||||||||||||
|
loading...
/
|
|||||||||||||||||||||||
References
- [1]. Benedetto Tiz D, et al. New Halogen-Containing Drugs Approved by FDA in 2021: An Overview on Their Syntheses and Pharmaceutical Use. Molecules (Basel, Switzerland). 2022 Mar 02;27(5):1643. [Content Brief]
- [2]. Kossakowski K, et al. FDA-approved kinase inhibitors in PROTAC design, development and synthesis. Journal of enzyme inhibition and medicinal chemistry. 2025 Dec;40(1):2542357. [Content Brief]
- [3]. Mulik B M, et al. Synthesis, Biological Evaluation, Molecular Docking and ADME Profiling of Methylpiperidin‑4‑ylphenyl‑nicotinamide Derivatives. ChemistrySelect, 2024, 9(14).
